Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) EBIT per Share : $0.03 (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings EBIT per Share?

Integrated Diagnostics Holdings's EBIT per Share for the three months ended in Mar. 2024 was $0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.03.

During the past 12 months, the average EBIT per Share Growth Rate of Integrated Diagnostics Holdings was -68.80% per year. During the past 3 years, the average EBIT per Share Growth Rate was -26.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was -6.30% per year. During the past 10 years, the average EBIT per Share Growth Rate was 7.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Integrated Diagnostics Holdings's EBIT per Share or its related term are showing as below:

IDGXF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -26.7 Med: 5 Max: 55.2
Current: -26.7

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Integrated Diagnostics Holdings was 55.20% per year. The lowest was -26.70% per year. And the median was 5.00% per year.

IDGXF's 3-Year EBIT Growth Rate is ranked worse than
79.89% of 174 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.65 vs IDGXF: -26.70

Integrated Diagnostics Holdings's EBIT for the three months ended in Mar. 2024 was $12.00 Mil.

Integrated Diagnostics Holdings EBIT per Share Historical Data

The historical data trend for Integrated Diagnostics Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings EBIT per Share Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.09

0.11

0.25

0.07

0.05

Integrated Diagnostics Holdings Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial															0.02	0.01	0.01	-	0.02

Integrated Diagnostics Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Integrated Diagnostics Holdings's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	28.438	/	600.000
=	0.05

Integrated Diagnostics Holdings's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	12.004	/	600.000
=	0.02

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03

Integrated Diagnostics Holdings (OTCPK:IDGXF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Integrated Diagnostics Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021